Cargando…

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor

The first synthetic cannabinoid receptor agonists (SCRAs) were designed as tool compounds to study the endocannabinoid system’s two predominant cannabinoid receptors, CB1R and CB2R. Unfortunately, novel SCRAs now represent the most rapidly proliferating novel psychoactive substances (NPS) of abuse g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zagzoog, Ayat, Brandt, Asher L., Black, Tallan, Kim, Eunhyun D., Burkart, Riley, Patel, Mikin, Jin, Zhiyun, Nikolaeva, Maria, Laprairie, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134483/ https://www.ncbi.nlm.nih.gov/pubmed/34012003 http://dx.doi.org/10.1038/s41598-021-90167-w

Ejemplares similares

Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes
por: Kim, Hye Ji J., et al.
Publicado: (2022)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
por: Zagzoog, Ayat, et al.
Publicado: (2020)

Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling
por: Laprairie, Robert B., et al.
Publicado: (2019)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
por: Brandt, Asher L., et al.
Publicado: (2022)

In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors
por: Kim, Hye Ji J., et al.
Publicado: (2021)

Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure
por: Black, Tallan, et al.
Publicado: (2023)

Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
por: Kim, Hye Ji J., et al.
Publicado: (2023)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
por: Gado, Francesca, et al.
Publicado: (2022)

New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
por: Faúndez-Parraguez, Manuel, et al.
Publicado: (2021)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
por: Diez-Alarcia, Rebeca, et al.
Publicado: (2016)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Cannabinoid receptors distribution in mouse cortical plasma membrane compartments
por: Miranzadeh Mahabadi, Hajar, et al.
Publicado: (2021)

Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB(1)R) Antagonist
por: Liu, Ziyi, et al.
Publicado: (2021)

Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2
por: Cécyre, Bruno, et al.
Publicado: (2020)

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
por: Ferrisi, Rebecca, et al.
Publicado: (2023)

Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor
por: Ospanov, Meirambek, et al.
Publicado: (2022)

Structure-Based Virtual Screening and Molecular Dynamics Simulation Assessments of Depsidones as Possible Selective Cannabinoid Receptor Type 2 Agonists
por: Mohamed, Gamal A., et al.
Publicado: (2023)

Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists
por: Gianella-Borradori, Matteo, et al.
Publicado: (2015)

Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis
por: Porter, Richard Frederick, et al.
Publicado: (2019)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

Cannabinoid receptor type-1: breaking the dogmas
por: Busquets Garcia, Arnau, et al.
Publicado: (2016)

“The Cannabinoid Receptors”
por: Reznicek, Gottfried
Publicado: (2010)

Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium
por: Assimakopoulou, Martha, et al.
Publicado: (2017)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

CB1 Cannabinoid Receptor Signaling and Biased Signaling
por: Leo, Luciana M., et al.
Publicado: (2021)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
por: Alapafuja, Shakiru O., et al.
Publicado: (2019)

Structural basis of selective cannabinoid CB(2) receptor activation
por: Li, Xiaoting, et al.
Publicado: (2023)

Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2023)

The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
por: Nam, Gaewon, et al.
Publicado: (2016)

The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg
por: McElroy, Dan L., et al.
Publicado: (2022)

The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice
por: McDonnell, Christina, et al.
Publicado: (2017)

Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum
por: Toschi, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cju1bi1nevtctkhs45okpnq9gf